191 related articles for article (PubMed ID: 23714324)
1. Effects of the opioid receptor antagonist naltrexone on smoking and related behaviors in smokers preparing to quit: a randomized controlled trial.
King A; Cao D; Zhang L; Rueger SY
Addiction; 2013 Oct; 108(10):1836-44. PubMed ID: 23714324
[TBL] [Abstract][Full Text] [Related]
2. Naltrexone improves quit rates, attenuates smoking urge, and reduces alcohol use in heavy drinking smokers attempting to quit smoking.
Fridberg DJ; Cao D; Grant JE; King AC
Alcohol Clin Exp Res; 2014 Oct; 38(10):2622-9. PubMed ID: 25335648
[TBL] [Abstract][Full Text] [Related]
3. Naltrexone decreases heavy drinking rates in smoking cessation treatment: an exploratory study.
King A; Cao D; Vanier C; Wilcox T
Alcohol Clin Exp Res; 2009 Jun; 33(6):1044-50. PubMed ID: 19302083
[TBL] [Abstract][Full Text] [Related]
4. A Double-Blind Randomized Placebo-Controlled Trial of Oral Naltrexone for Heavy-Drinking Smokers Seeking Smoking Cessation Treatment.
Kahler CW; Cioe PA; Tzilos GK; Spillane NS; Leggio L; Ramsey SE; Brown RA; O'Malley SS
Alcohol Clin Exp Res; 2017 Jun; 41(6):1201-1211. PubMed ID: 28401564
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological effects of naltrexone and intravenous alcohol on craving for cigarettes among light smokers: a pilot study.
Ray LA; Miranda R; Kahler CW; Leventhal AM; Monti PM; Swift R; Hutchison KE
Psychopharmacology (Berl); 2007 Sep; 193(4):449-56. PubMed ID: 17484067
[TBL] [Abstract][Full Text] [Related]
6. Effects of naltrexone on smoking cessation outcomes and weight gain in nicotine-dependent men and women.
King AC; Cao D; O'Malley SS; Kranzler HR; Cai X; deWit H; Matthews AK; Stachoviak RJ
J Clin Psychopharmacol; 2012 Oct; 32(5):630-6. PubMed ID: 22926596
[TBL] [Abstract][Full Text] [Related]
7. Nicotine-Use/Smoking Is Associated with the Efficacy of Naltrexone in the Treatment of Alcohol Dependence.
Anton RF; Latham PK; Voronin KE; Randall PK; Book SW; Hoffman M; Schacht JP
Alcohol Clin Exp Res; 2018 Apr; 42(4):751-760. PubMed ID: 29431852
[TBL] [Abstract][Full Text] [Related]
8. Opioid antagonists for smoking cessation.
David S; Lancaster T; Stead LF; Evins AE
Cochrane Database Syst Rev; 2006 Oct; (4):CD003086. PubMed ID: 17054160
[TBL] [Abstract][Full Text] [Related]
9. A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.
O'Malley SS; Cooney JL; Krishnan-Sarin S; Dubin JA; McKee SA; Cooney NL; Blakeslee A; Meandzija B; Romano-Dahlgard D; Wu R; Makuch R; Jatlow P
Arch Intern Med; 2006 Mar; 166(6):667-74. PubMed ID: 16567607
[TBL] [Abstract][Full Text] [Related]
10. Opioid antagonists for smoking cessation.
David S; Lancaster T; Stead LF
Cochrane Database Syst Rev; 2001; (3):CD003086. PubMed ID: 11687036
[TBL] [Abstract][Full Text] [Related]
11. Lack of Association between Opioid-Receptor Genotypes and Smoking Cessation Outcomes in a Randomized, Controlled Naltrexone Trial.
Roche DJO; Trela CJ; Argos M; Jasmine F; Kibriya MG; Ahsan H; King AC
Alcohol Alcohol; 2019 Jan; 54(5):559-565. PubMed ID: 31206155
[TBL] [Abstract][Full Text] [Related]
12. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of naltrexone in smoking cessation: a preliminary study and an examination of sex differences.
King A; de Wit H; Riley RC; Cao D; Niaura R; Hatsukami D
Nicotine Tob Res; 2006 Oct; 8(5):671-82. PubMed ID: 17008194
[TBL] [Abstract][Full Text] [Related]
14. Mediators of the effect of nicotine pre-treatment on quitting smoking.
Hajek P; Lewis S; Munafo M; Lindson N; Coleman T; Aveyard P;
Addiction; 2018 Dec; 113(12):2280-2289. PubMed ID: 30066385
[TBL] [Abstract][Full Text] [Related]
15. Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings.
Ray LA; Courtney KE; Ghahremani DG; Miotto K; Brody A; London ED
Psychopharmacology (Berl); 2014 Oct; 231(19):3843-53. PubMed ID: 24733235
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction: A Randomized Clinical Trial.
Ray LA; Green R; Enders C; Leventhal AM; Grodin EN; Li G; Lim A; Hartwell E; Venegas A; Meredith L; Nieto SJ; Shoptaw S; Ho D; Miotto K
Am J Psychiatry; 2021 Sep; 178(9):818-828. PubMed ID: 34080890
[TBL] [Abstract][Full Text] [Related]
17. Effects of topiramate or naltrexone on tobacco use among male alcohol-dependent outpatients.
Baltieri DA; Daró FR; Ribeiro PL; Andrade AG
Drug Alcohol Depend; 2009 Nov; 105(1-2):33-41. PubMed ID: 19595518
[TBL] [Abstract][Full Text] [Related]
18. Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: a randomized trial.
Toll BA; White M; Wu R; Meandzija B; Jatlow P; Makuch R; O'Malley SS
Drug Alcohol Depend; 2010 Oct; 111(3):200-6. PubMed ID: 20542391
[TBL] [Abstract][Full Text] [Related]
19. Distress Tolerance and Craving for Cigarettes Among Heavy Drinking Smokers.
Lim AC; Roche DJO; Ray LA
J Stud Alcohol Drugs; 2018 Nov; 79(6):918-928. PubMed ID: 30573023
[TBL] [Abstract][Full Text] [Related]
20. Combined varenicline and naltrexone treatment reduces smoking topography intensity in heavy-drinking smokers.
Roche DJ; Bujarski S; Hartwell E; Green R; Ray LA
Pharmacol Biochem Behav; 2015 Jul; 134():92-8. PubMed ID: 25933795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
